World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
33266
World Ranking
15416
National Ranking
7776

Joel L. Weissfeld publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Joel L. Weissfeld sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 297 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Joel L. Weissfeld D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Joel L. Weissfeld sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Joel L. Weissfeld is a researcher affiliated with the University of Pittsburgh in the United States. Their work spans multiple fields, primarily focusing on medicine, pharmacology, toxicology, and pharmaceutics. They have contributed to subfields including pediatrics, perinatology, child health, public health, environmental and occupational health, and pharmacology.

Their recent research outputs include a publication titled "Regulatory Impact of Selected U.S. FDA Postmarketing Safety Registries Conducted for Drugs Used to Treat Inflammatory or Autoimmune Conditions", published in 2024 in the journal Pharmacoepidemiology and Drug Safety. This work addresses regulatory aspects related to drug safety in treatment contexts involving inflammatory or autoimmune conditions.

Their scholarly contributions largely concentrate on these main topics:

  • Pharmaceutical studies and practices
  • Pregnancy and medication impact
  • Pharmaceutical industry and healthcare

Joel L. Weissfeld has collaborated frequently with colleagues such as Zakaridja Guiriansoro and Tatiana Oussova. These collaborations intersect with their shared interest in pharmacological and medical research.

In terms of publication venues, Weissfeld's work has appeared notably in Pharmacoepidemiology and Drug Safety, reflecting a targeted dissemination of findings within the domain of drug safety and pharmacoepidemiology.

The researcher's focus on pregnancy and medication impact, alongside pharmaceutical studies more broadly, indicates an engagement with both clinical and regulatory dimensions of drug development and healthcare practice. Their involvement in public health areas highlights the importance of environmental and occupational factors in medicine.

Best Publications

  • Mortality Results from a Randomized Prostate-Cancer Screening Trial

    Gerald L. Andriole;E. David Crawford;Robert L. Grubb;Saundra S. Buys

  • The Mutational Landscape of Head and Neck Squamous Cell Carcinoma

    N. Stransky;A. M. Egloff;A. D. Tward;A. D. Kostic

  • Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.

    Saundra S. Buys;Edward Partridge;Amanda Black;Christine C. Johnson

  • Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up

    Gerald L. Andriole;E. David Crawford;Robert L. Grubb;Saundra S. Buys

  • The national lung screening trial: Overview and study design

    Constantine A. Gatsonis;Denise R. Aberle;Christine D. Berg;William C. Black

  • Lack of Effect of a Low-Fat, High-Fiber Diet on the Recurrence of Colorectal Adenomas

    A Schatzkin;E Lanza;D Corle;P Lance

  • Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy

    Robert E. Schoen;Paul F. Pinsky;Joel L. Weissfeld;Lance A. Yokochi

  • Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial

    Philip C Prorok;Gerald L Andriole;Robert S. Bresalier;Saundra S Buys

  • Screening by Chest Radiograph and Lung Cancer Mortality: The Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Trial

    Martin M. Oken;Willam G. Hocking;Paul A. Kvale;Gerald L. Andriole

  • Association of Radiographic Emphysema and Airflow Obstruction with Lung Cancer

    David O. Wilson;Joel L. Weissfeld;Arzu Balkan;Arzu Balkan;Jeffrey G. Schragin

  • Analysis of Colorectal Cancer Occurrence During Surveillance Colonoscopy in the Dietary Polyp Prevention Trial

    Ajay Pabby;Robert E. Schoen;Joel L. Weissfeld;Randall Burt

  • "White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan.

    S Julius;A Mejia;K Jones;L Krause

  • Results from four rounds of ovarian cancer screening in a randomized trial

    Edward Partridge;Aimee R. Kreimer;Robert T. Greenlee;Craig Williams

  • Factors associated with Type I and Type II endometrial cancer.

    Ashley S. Felix;Joel L. Weissfeld;Roslyn A. Stone;Robert Bowser

  • Hyperkinetic borderline hypertension in Tecumseh, Michigan.

    Stevo Julius;Lisa Krause;Nicholas J. Schork;Agnes D. Mejia

  • The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan.

    David O. Wilson;Joel L. Weissfeld;Carl R. Fuhrman;Stephen N. Fisher

  • Unlocking Biomarker Discovery: Large Scale Application of Aptamer Proteomic Technology for Early Detection of Lung Cancer

    Rachel M. Ostroff;William L. Bigbee;Wilbur Franklin;Larry Gold

  • Meat, Meat Cooking Methods and Preservation, and Risk for Colorectal Adenoma

    Rashmi Sinha;Ulrike Peters;Amanda J Cross;Martin Kulldorff

  • Utilization of surveillance colonoscopy in community practice.

    Robert E. Schoen;Paul F. Pinsky;Joel L. Weissfeld;Lance A. Yokochi

  • Flexible Sigmoidoscopy in the PLCO Cancer Screening Trial: Results From the Baseline Screening Examination of a Randomized Trial

    Joel L. Weissfeld;Robert E. Schoen;Paul F. Pinsky;Robert S. Bresalier

Frequent Co-Authors

Robert E. Schoen
Robert E. Schoen University of Pittsburgh
Jill M. Siegfried
Jill M. Siegfried University of Minnesota
Frank C. Sciurba
Frank C. Sciurba University of Pittsburgh
Paul F. Pinsky
Paul F. Pinsky National Institutes of Health
Timothy R. Church
Timothy R. Church University of Minnesota
Richard B. Hayes
Richard B. Hayes New York University
Lewis H. Kuller
Lewis H. Kuller University of Pittsburgh
Jennifer R. Grandis
Jennifer R. Grandis University of California, San Francisco
Harvey O. Coxson
Harvey O. Coxson University of British Columbia
Bette J. Caan
Bette J. Caan Kaiser Permanente

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine isn’t limited to traditional medical degrees. There are a variety of nutrition degrees online for students interested in health and dietetics. These programs can lead to roles in public health, wellness coaching, or food science.

If you’re looking to advance your administrative skills, consider cahme–accredited online Master of Healthcare Administration (MHA) programs. These programs meet rigorous standards and prepare graduates for leadership positions in healthcare organizations.

For nurses, there are flexible educational pathways, including rn bsn online programs no clinicals. These options allow registered nurses to earn a Bachelor of Science in Nursing without the need for additional clinical hours, making them suitable for working professionals.

Nurses aspiring for the highest clinical roles can explore the fastest dnp online program, offering a quick and convenient route to a Doctor of Nursing Practice degree. These pathways broaden career options in nursing leadership and advanced practice roles.

Best Scientists Citing Joel L. Weissfeld

Trending Scientists

Recently Published Articles